Search Results

The prognosis of severe subclinical hyperthyroidism with TSH below 0.1 μU/mL due to Graves' disease in the Japanese population.

• Authors : Nishijima Y; Department of Endocrinology, Noguchi Thyroid Clinic and Hospital Foundation, Oita 874-0902, Japan.; Murakami T

Subjects: Graves Disease*/Graves Disease*/Graves Disease*/blood ; Graves Disease*/Graves Disease*/Graves Disease*/diagnosis ; Graves Disease*/Graves Disease*/Graves Disease*/complications

• Source: Endocrine journal [Endocr J] 2025 Jun 02; Vol. 72 (6), pp. 689-695. Date of Electronic Publication: 2025 Feb 26.Publisher: Japan Endocrine Society Country of Publication: Japan NLM ID: 9313485 Publication Model:

Record details

A narrative review of long-term inorganic iodine monotherapy for Graves' disease with a historical relationship between iodine and thyroid.

• Authors : Watanabe N; Department of Internal Medicine, Ito Hospital, Tokyo 150-8308, Japan.

Subjects: Graves Disease*/Graves Disease*/Graves Disease*/drug therapy ; Iodine*/Iodine*/Iodine*/administration & dosage ; Iodine*/Iodine*/Iodine*/therapeutic use

• Source: Endocrine journal [Endocr J] 2025 Jan 06; Vol. 72 (1), pp. 23-36. Date of Electronic Publication: 2024 Sep 05.Publisher: Japan Endocrine Society Country of Publication: Japan NLM ID: 9313485 Publication Model:

Record details

New-onset graves' disease after the initiation of nivolumab therapy for gastric cancer: a case report.

• Authors : Yamada H; Department of Endocrinology, Diabetes and Metabolism, Graduate School of Medicine, Nippon Medical School, 1-1-5, Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan. .; Okajima F

Subjects: Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*drug therapy ; Graves Disease/Graves Disease/Graves Disease/*chemically induced ; Nivolumab/Nivolumab/Nivolumab/*adverse effects

• Source: BMC endocrine disorders [BMC Endocr Disord] 2020 Aug 26; Vol. 20 (1), pp. 132. Date of Electronic Publication: 2020 Aug 26.Publisher: BioMed Central Country of Publication: England NLM ID: 101088676 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6823

Record details

Guidelines for the treatment of childhood-onset Graves' disease in Japan, 2016.

• Authors : Kanshi Minamitani¹ ; Hirokazu Sato²; Hidemi Ohye³

• Source: Clinical Pediatric Endocrinology. Apr2017, Vol. 26 Issue 2, p29-62. 34p.

Record details

Construction of a population-specific HLA imputation reference panel and its application to Graves' disease risk in Japanese.

• Authors : Okada, Yukinori¹; Momozawa, Yukihide²; Ashikawa, Kyota²

• Source: Nature Genetics. Jul2015, Vol. 47 Issue 7, p798-802. 5p. 3 Color Photographs, 1 Chart.

Record details

Calcium and its Regulating Hormones in Patients with Graves Disease: Sex Differences and Relation to Postoperative Tetany.

• Authors : Yamashita, Hiroyuki¹; Noguchi, Shiro; Murakami, Tukasa

• Source: European Journal of Surgery. Dec2000, Vol. 166 Issue 12, p924-928. 5p. 3 Charts, 5 Graphs.

Record details

Serum human chorionic gonadotropin levels and thyroid hormone levels in gestational transient thyrotoxicosis: Is the serum hCG level useful for differentiating between active Graves' disease and GTT?

• Authors : Yoshihara A; Ito Hospital, Tokyo 150-8308, Japan.; Noh JY

Subjects: Chorionic Gonadotropin/Chorionic Gonadotropin/Chorionic Gonadotropin/*blood ; Graves Disease/Graves Disease/Graves Disease/*blood ; Pregnancy Complications/Pregnancy Complications/Pregnancy Complications/*blood Thyroiditis, Chronic

• Source: Endocrine journal [Endocr J] 2015; Vol. 62 (6), pp. 557-60. Date of Electronic Publication: 2015 Mar 29.Publisher: Japan Endocrine Society Country of Publication: Japan NLM ID: 9313485 Publication Model:

Record details

Prediction of late (24-hour) radioactive iodine uptake using early (3-hour) uptake values in Japanese patients with Graves' disease.

• Authors : Osaki Y; Department of Endocrinology and Metabolism, Federation of National Public Service and Affiliated Personnel Mutual Aid Associations, Suifu Hospital, Mito, Japan. ; Sakurai K

Subjects: Iodine* ; Radiopharmaceuticals*; Graves Disease/Graves Disease/Graves Disease/*diagnosis

• Source: Endocrine journal [Endocr J] 2012; Vol. 59 (2), pp. 173-7. Date of Electronic Publication: 2011 Nov 18.Publisher: Japan Endocrine Society Country of Publication: Japan NLM ID: 9313485 Publication Model:

Record details

Simultaneous occurrence of type 1 diabetes mellitus and Graves' disease: a report of two cases and a review of the literature.

• Authors : Mizokami T; Division of Endocrinology and Metabolism, St. Mary's Hospital, Japan.; Yamauchi A

Subjects: Diabetes Mellitus, Type 1/Diabetes Mellitus, Type 1/Diabetes Mellitus, Type 1/*complications ; Graves Disease/Graves Disease/Graves Disease/*complications ; Polyendocrinopathies, Autoimmune/Polyendocrinopathies, Autoimmune/Polyendocrinopathies, Autoimmune/*genetics

• Source: Internal medicine (Tokyo, Japan) [Intern Med] 2013; Vol. 52 (22), pp. 2537-43.Publisher: Japanese Society of Internal Medicine Country of Publication: Japan NLM ID: 9204241 Publication Model: Print Cited

Record details

Drug discontinuation after treatment with minimum maintenance dose of an antithyroid drug in Graves' disease: a retrospective study on effects of treatment duration with minimum maintenance dose on lasting remission.

• Authors : Konishi T; Sumire Hospital, Osaka Social Welfare Foundation, 1-20-85, Furuichi, Joto-ku,Osaka 536-0001, Japan. ; Okamoto Y

Subjects: Antithyroid Agents/Antithyroid Agents/Antithyroid Agents/*administration & dosage ; Graves Disease/Graves Disease/Graves Disease/*drug therapy; Adolescent

• Source: Endocrine journal [Endocr J] 2011; Vol. 58 (2), pp. 95-100. Date of Electronic Publication: 2010 Dec 28.Publisher: Japan Endocrine Society Country of Publication: Japan NLM ID: 9313485 Publication Model:

Record details